Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-3.35 Insider Own10.72% Shs Outstand22.05M Perf Week-3.01%
Market Cap92.39M Forward P/E- EPS next Y-1.22 Insider Trans15.57% Shs Float19.68M Perf Month-12.53%
Income-45.01M PEG- EPS next Q-0.54 Inst Own26.40% Short Float4.14% Perf Quarter49.64%
Sales2.17M P/S42.58 EPS this Y26.85% Inst Trans-1.63% Short Ratio3.03 Perf Half Y-12.89%
Book/sh1.26 P/B3.34 EPS next Y59.63% ROA-132.78% Short Interest0.81M Perf Year-13.43%
Cash/sh1.84 P/C2.28 EPS next 5Y15.00% ROE-462.32% 52W Range2.25 - 7.99 Perf YTD0.72%
Dividend Est.- P/FCF- EPS past 5Y92.89% ROI-161.75% 52W High-47.56% Beta0.51
Dividend TTM- Quick Ratio3.11 Sales past 5Y10.75% Gross Margin45.13% 52W Low86.22% ATR (14)0.22
Dividend Ex-Date- Current Ratio3.30 EPS Y/Y TTM11.62% Oper. Margin-1604.30% RSI (14)44.62 Volatility3.60% 4.85%
Employees52 Debt/Eq0.45 Sales Y/Y TTM-48.32% Profit Margin-2079.17% Recom1.00 Target Price19.25
Option/ShortYes / Yes LT Debt/Eq0.13 EPS Q/Q-23.38% Payout- Rel Volume0.20 Prev Close4.17
Sales Surprise-36.42% EPS Surprise-119.23% Sales Q/Q-52.10% EarningsNov 13 AMC Avg Volume268.62K Price4.19
SMA20-6.25% SMA50-1.80% SMA200-6.93% Trades Volume54,251 Change0.48%
Date Action Analyst Rating Change Price Target Change
Jul-26-22Resumed Canaccord Genuity Buy $17
Dec-10-21Initiated H.C. Wainwright Buy $25
Mar-09-21Initiated Canaccord Genuity Buy $24
Jan-05-21Initiated BTIG Research Buy $23
Jun-01-20Initiated Laidlaw Buy $19
Feb-22-24 05:00PM
Feb-16-24 05:00PM
Jan-31-24 08:00AM
Jan-23-24 08:00AM
Jan-16-24 08:00AM
05:00PM Loading…
Jan-12-24 05:00PM
Dec-15-23 01:02PM
Dec-07-23 09:00AM
Nov-15-23 05:00PM
Nov-13-23 04:05PM
Nov-06-23 04:30PM
Oct-16-23 08:30AM
Oct-10-23 08:30AM
Oct-03-23 08:30AM
Sep-27-23 04:05PM
09:59AM Loading…
Sep-14-23 09:59AM
Sep-11-23 08:00AM
Sep-05-23 04:00PM
Sep-01-23 02:07PM
Aug-29-23 08:00AM
Aug-14-23 09:10PM
Aug-12-23 09:02AM
Aug-09-23 05:33PM
Aug-03-23 08:30AM
Jun-21-23 04:10PM
Jun-20-23 08:30AM
Jun-07-23 04:10PM
May-12-23 08:00AM
May-09-23 09:00AM
May-03-23 08:30AM
04:30PM Loading…
Apr-03-23 04:30PM
Mar-29-23 09:41PM
Mar-27-23 03:15PM
Feb-16-23 08:30AM
Feb-14-23 08:49AM
Jan-30-23 08:30AM
Jan-17-23 08:00AM
Dec-16-22 04:15PM
Dec-13-22 08:30AM
Dec-08-22 08:30AM
Dec-05-22 09:00AM
Nov-09-22 04:15PM
Nov-08-22 08:00AM
Oct-24-22 04:05PM
Sep-01-22 04:15PM
Aug-08-22 07:45AM
Aug-05-22 08:30AM
Jul-27-22 04:30PM
Jul-20-22 04:10PM
Jul-18-22 08:30AM
Jun-07-22 07:06AM
Jun-06-22 04:15PM
May-10-22 07:30AM
May-09-22 08:30AM
May-02-22 03:02PM
Apr-28-22 09:00AM
Apr-08-22 09:00AM
Mar-29-22 09:00AM
Mar-25-22 07:30AM
Mar-15-22 04:30PM
Mar-10-22 09:00AM
Mar-02-22 04:01PM
Feb-22-22 09:00AM
Feb-10-22 04:30PM
Feb-07-22 04:01PM
Feb-04-22 09:00AM
Feb-03-22 04:30PM
Jan-25-22 04:01PM
Jan-07-22 09:00AM
Dec-02-21 08:00AM
Nov-30-21 08:30AM
Nov-11-21 06:06AM
Nov-09-21 07:30AM
Nov-08-21 12:49PM
Nov-05-21 09:00AM
Nov-02-21 03:02PM
Oct-25-21 04:01PM
Sep-02-21 09:00AM
Aug-10-21 07:30AM
Aug-09-21 07:30AM
Aug-05-21 09:00AM
Aug-03-21 03:00PM
Jul-28-21 09:00AM
Jul-08-21 11:20AM
Jul-07-21 09:00AM
Jun-23-21 09:35AM
Jun-08-21 09:00AM
Jun-07-21 12:21PM
Jun-03-21 09:00AM
May-26-21 09:00AM
May-24-21 06:17AM
May-11-21 08:00AM
May-03-21 02:33AM
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded in August 1988 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vukovic VojoChief Medical OfficerDec 12Buy3.0040,000120,000100,000Dec 14 04:20 PM
MICHEL GERARD JChief Executive OfficerDec 08Buy2.9434,00099,960262,345Dec 11 05:02 PM
Rosalind Advisors, Inc.DirectorNov 17Buy2.40100,000240,4101,038,828Nov 21 11:07 AM
Pennell SandraSVP of Finance, PFO and PAONov 17Buy2.4330,00072,90030,000Nov 21 07:42 AM
Vukovic VojoChief Medical OfficerNov 16Buy2.4860,000148,80060,000Nov 20 04:22 PM
Hoffman David L.See RemarksNov 16Buy2.4840,00099,20040,000Nov 20 04:20 PM
Purpura JohnChief Operating OfficerOct 13Buy3.4414,50549,89741,526Oct 17 04:53 PM
Sylvester John RichardDirectorAug 21Buy4.8010,55050,64010,550Aug 23 11:03 AM
MICHEL GERARD JChief Executive OfficerMar 29Buy4.8419,64695,087197,235Mar 30 09:00 AM